Linker Information
General Information of This Linker
Linker ID |
LIN0NAIOB
|
|||||
---|---|---|---|---|---|---|
Linker Name |
Glucuronide quaternary ammonium linker 8
|
|||||
Antibody-Linker Relation |
Cleavable
|
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
Alpha-CD30-8 [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Tumor Growth Inhibition value (TGI) | ≈ 97.10% (Day 28) | Positive CD30 expression (CD30+++/++) | ||
Method Description |
Alpha-CD30-8 (0.3 m ug/kg, every seven days x3) induces efficient tumor cell killing in cell line-derived models of CD30+, MDR-L540cy HL cells with CD30 expression with high expression.
|
||||
In Vivo Model | L540cy CDX model | ||||
In Vitro Model | Hodgkin's disease | L540cy cells | Homo sapiens | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Tumor Growth Inhibition value (TGI) | ≈ 99.20% (Day 16) | Positive CD30 expression (CD30+++/++) | ||
Method Description |
Alpha-CD30-8 (1 m ug/kg, every seven days x3) induces efficient tumor cell killing in cell line-derived models of CD30+, MDR+ DEL/BVR ALCL cells with CD30 expression with high expression.
|
||||
In Vivo Model | DEL/BVR CDX model | ||||
In Vitro Model | Anaplastic large cell lymphoma | DEL/BVR cells | CVCL_1170 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.